Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
$345 million in gross proceeds raised in upsized IPO, providing a projected operating runway into 4Q 2026
Source: eagletribune.com
Page 17 - Dan Budwick News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dan Budwick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dan Budwick Today - Breaking & Trending Today
Gritstone bio and Genevant Sciences Announce Option and License Agreement
Agreement provides nonexclusive access to Genevant’s leading LNP technology for use with Gritstone bio’s self-amplifying RNA technology in wide array of infectious disease vaccines Multi-year, multi-pathogen, option-based deal follows multiple successful prior collaborations between Gritstone and Genevant EMERYVILLE, Calif., VANCOUVER, British Columbia, and BASEL, Switzerland, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims t
Source: yahoo.com
Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
Structure Therapeutics reported financial results for the second quarter June 30, 2023, and highlighted recent corporate achievements.
Source: medindia.net
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
BEACON Trial of BEAM-101 in Sickle Cell Disease Progressing with Consented Patients Projected to Fill Sentinel Cohort and to Initiate Expansion Cohort First Patient Consented in Phase 1/2 Trial of...
Source: marketscreener.com
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
Structure Therapeutics announced that it has appointed Ted W. Love, M.D., to its Board of Directors
Source: medindia.net